rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Bill Facteau

Director

Company insider

Files Form 4 as: Director, BioCardia.

In numbers

Trades disclosed
8
Buys
1
Sells
0
Bought
$25K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
18 Oct 2023
Last trade
6 Jul 2026
Last filed
7 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BCDA BioCardiaDirector · Biotechnology · last 6 Jul 20261 buy · 0 sells

Activity over time

1 Apr 2025 – 1 Oct 2026
01Apr 25Sep 25Jan 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
6 Jul 2026filed 7 Jul 2026BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
6 Jul 2026filed 7 Jul 2026BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
8 Dec 2025filed 10 Dec 2025BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—12,000 at $0.00filing
23 Apr 2025filed 25 Apr 2025BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code P—13,123filing
23 Apr 2025filed 25 Apr 2025BCDA BioCardiaBiotechnologySEC FORM 4 Bought$25K13,123 at $1.91filing
11 Oct 2024filed 16 Oct 2024BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—829 at $0.00filing
18 Oct 2023filed 19 Oct 2023BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—31,085 at $0.00filing
18 Oct 2023filed 19 Oct 2023BCDA BioCardiaoption or derivative · BiotechnologySEC FORM 4 Code A—12,434 at $0.00filing

News

BioCardia (NASDAQ:BCDA) Stock Falls 5.5% – What's Next?BCDA · dailypolitical.com · 23 Oct 2026BioCardia Advances Helix Catheter Toward FDA Marketing ClearanceBCDA · rttnews.com · 19 Oct 2026

0 headlines in the last 90 days name Bill Facteau; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Peter AltmanPresident and CEO · President and CEO at BioCardia, filing Form 4 there in the last year
Jay M. MoyesDirector · Director at BioCardia, filing Form 4 there in the last year
Edward M. GillisSenior Vice President, Devices · Senior Vice President, Devices at BioCardia, filing Form 4 there in the last year
David McClungChief Financial Officer · Chief Financial Officer at BioCardia, filing Form 4 there in the last year
Jim L. AllenDirector · Director at BioCardia, filing Form 4 there in the last year